Crystalys was co-founded by the Executive Team, Catalys Pacific and Novo Holdings, organizations with extensive experience supporting the development and growth of biotechnology companies. The company’s leadership team brings deep expertise in drug development, clinical research, and global regulatory strategy.
Crystalys is focused on advancing innovative therapies that address the unmet needs of patients with gout while continuing to build a company grounded in scientific rigor and clinical excellence.
upcoming events
- Morgan Stanley Healthcare Conference, New York – September 14-16
- Novo CEO Summit – September 22-24
- G-CAN, Orlando – November 4-5
- ACR Convergence 2026, Orlando – November 6-11
- Jefferies London Healthcare Conference, London – November 16-19
- UBS Global Healthcare Conference 2026, Palm Beach – November 18-19
Crystalys Therapeutics was co-founded by Catalys Pacific and Novo Holdings